Clinical trials
Observational Breast Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 8 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Unknown status | 15 |
| Recruiting | 14 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spanish Breast Cancer Research Group | 11 |
| SOLTI Breast Cancer Research Group | 4 |
| AstraZeneca | 3 |
| Hoffmann-La Roche | 3 |
| Instituto de Investigacion Sanitaria La Fe | 3 |
| MedSIR | 3 |
| Parc de Salut Mar | 3 |
| Corporacion Parc Tauli | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Hospital Universitari de Bellvitge | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 86 |
| Neoplasms | 5 |
| Colonic Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
| Alopecia | 1 |
| Bone Diseases, Metabolic | 1 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.